semaglutide novo nordisk to launch Ozempic for type 2 diabetes in US Novo Nordisk's Ozempic slows diabetic
Description
However, the high cost and frequent shortages of these FDA-approved drugs have led employers and patients to explore compounded GLP-1 medications as an alternative
Response to shifting consumer trends reverberating throughout the supply chain.
Despite these promising findings, further research is necessary to establish their long-term efficacy, optimal dosing strategies, and potential synergistic interactions of GLP-1RAs with existing pain management therapies
:max_bytes(150000):strip_icc()/GettyImages-2186482541-b5eda0fcf8804c42a77ef0d338260a7e.jpg)
Reconstituted retatrutide is stable 28-60 days at 36-46F (2-8C)
